Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Agilent Technologies Inc.
Headquarters: Santa Clara, CA, United States of America
Website: http://www.agilent.com
Year Founded: 1999
Status: Public
Industry Sector: HealthTechnology
CEO: Padraig Mcdonnell
Number Of Employees: 17,900
Enterprise Value: $40,165,210,000
PE Ratio: 23.67
Exchange/Ticker 1: NYSE:A
Exchange/Ticker 2: N/A
Latest Market Cap: $29,365,608,448
BioCentury | Sep 18, 2024
Management Tracks
New CEOs at Nura, IMU
Plus: Structure strengthens team and updates from RegenxBio, Mirador, Abata, Entact, Nautilus and more
BioCentury | May 2, 2024
Management Tracks
McDonnell now CEO of Agilent
Plus: Dubensky to lead ImmuneSensor and updates from NORD and Epsilogen
BioCentury | Apr 16, 2024
Deals
Deals report: Vertex’s biggest deal yet, and more
Novartis gets two androgen receptor protein degraders from Arvinas and Genentech-Adaptimmune terminate allogeneic T cell therapy deal
BioCentury | Dec 7, 2023
Management Tracks
Versanis vet Pruzanski becomes Abcuro’s chair
Plus: Alentis hires Velji as CBO and updates from Empress, Ribbon, Octave, Camena, OM and Transgene
BioCentury | Nov 2, 2023
Management Tracks
Sam Raha named COO at Myriad
Plus: Endeavor hires a new CMO, and updates from Jasper, Syantra, Ocuphire, Senisca and more
BioCentury | Sep 6, 2023
Management Tracks
Thaysen leaving Agilent to become CEO of Illumina
Plus: Josh Schimmer, Eric Schmidt join Cantor
BioCentury | May 11, 2023
Management Tracks
McKinsey vet Dewhurst joins Lightrock
Plus: Wugen appoints Alles as chair and updates from Cerevel, Ribbon, Immodulon and more
BioCentury | Mar 15, 2023
Finance
March 14 Quick Takes: Switch launches with $52M and conditional gene knockdown tech
Plus: Servier’s vorasidenib meets glioma endpoint and updates from Teitur, AlgoTx, GSK, Acesion, Sophia Genetics and more
BioCentury | Jun 2, 2022
Management Tracks
Anderson to lead Pfizer’s vaccine R&D
Plus CFO Luca Scavo resigns from Evelo, Passage Bio’s CEO steps down, and updates from MindMaze, Black Diamond and more
BioCentury | Mar 16, 2022
Deals
March 15 Quick Takes: Blackstone backs Sanofi’s multiple myeloma trial
Plus: Keytruda, Lynparza combo misses, pandemic antiviral initiative launches and updates from Eisai, Biogen and more
Items per page:
1 - 10 of 250